It’s more than a financial blow; it’s a betrayal of the families who are depending on breakthroughs in cancer treatment, ...

The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.

The latest example of this trend is Merck KGaA’s impending all-cash acquisition of SpringWorks Therapeutics, valued around ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc. GILD gained following the earnings beat and upbeat guidance for 2025 ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved… accelant, a leader in sales, marketing, and revenue operations, is thrilled to announc ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

TechCrunch’s Startup Battlefield 200 is where the world’s most innovative early-stage startups take center stage in a pitch competition like no other. With over 1,500 alumni like Trello ...